Long-term Experience With Abatacept SC in Routine Clinical Practice
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Jun 2019
Price : $35 *
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms ASCORE
- Sponsors Bristol-Myers Squibb
- 15 Jun 2019 Interim results of Ascore trial assessing abatacept for the treatment of rheumatoid arthritis presented at the 20th Annual Congress of the European League Against Rheumatism
- 13 Nov 2018 Planned End Date changed from 31 Dec 2018 to 31 Dec 2019.
- 13 Nov 2018 Planned primary completion date changed from 31 Dec 2018 to 30 Oct 2019.